Basit öğe kaydını göster

dc.contributor.authorKunter, Erdogan
dc.contributor.authorKaplan, Mustafa
dc.contributor.authorSolmazgul, Emrullah
dc.contributor.authorOncul, Oral
dc.contributor.authorYildirim, Sukru
dc.contributor.authorKucukardali, Yasar
dc.date.accessioned2021-03-03T20:48:38Z
dc.date.available2021-03-03T20:48:38Z
dc.date.issued2007
dc.identifier.citationKucukardali Y., Solmazgul E., Kunter E., Oncul O., Yildirim S., Kaplan M., "Kikuchi-Fujimoto Disease: analysis of 244 cases", CLINICAL RHEUMATOLOGY, cilt.26, sa.1, ss.50-54, 2007
dc.identifier.issn0770-3198
dc.identifier.otherav_5bf1b882-436d-4a56-9ef3-c6c0fc341a44
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/64485
dc.identifier.urihttps://doi.org/10.1007/s10067-006-0230-5
dc.description.abstractKikuchi-Fujimoto Disease (KFD) was first described in Japan in 1972. The disease frequently mimics tuberculous lymphadenitis, malign lymphoma, and many other benign and malignant conditions. To our knowledge, there is no previous study comparing the clinical and laboratory characteristics of patients from different geographical parts of the world. We searched literature records beginning from 1991 and analyzed epidemiological, clinical, and laboratory data of 244 patients (including cases diagnosed in our institution) reported in 181 publications. Of the 244 cases, 33% were male and 77% were female. Mean age was 25 (1-64) and 70% was younger than 30. Most of the cases were reported from Taiwan (36%), USA (6.6%), and Spain (6.3%). Fever (35%), fatigue (7%) and joint pain (7%) were the most frequent symptoms, while lymphadenomegaly (100%), erythematous rashes (10%), arthritis (5%), hepatosplenomegaly (3%), leucopenia (43%), high erythrocyte sedimentation rate (40%), and anemia (23%) being the most common findings. KFD was associated with SLE (32 cases), non-infectious inflammatory diseases (24 cases), and viral infections (17 cases). SLE was more frequent in cases from Asia than Europe (28 and 9%, respectively). The disease was self-limiting in 156 (64%) and corticosteroid treatment was necessary in 16 (16%) of the cases. The mortality rate was 2.1%. Early diagnosis is crucial as the clinical and laboratory presentation generally imitates situations needing lengthy and costly diagnostic and therapeutic interventions. Additionally, association with SLE needs further investigation.
dc.language.isoeng
dc.subjectİç Hastalıkları
dc.subjectİmmünoloji ve Romatoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectROMATOLOJİ
dc.titleKikuchi-Fujimoto Disease: analysis of 244 cases
dc.typeMakale
dc.relation.journalCLINICAL RHEUMATOLOGY
dc.contributor.department, ,
dc.identifier.volume26
dc.identifier.issue1
dc.identifier.startpage50
dc.identifier.endpage54
dc.contributor.firstauthorID2209488


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster